2012 年至 2017 年美国 Medicare 受益人群中贴斑试验的利用、成本和提供者趋势。

Utilization, cost, and provider trends in patch testing among Medicare beneficiaries in the United States from 2012 to 2017.

机构信息

Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.

出版信息

J Am Acad Dermatol. 2021 Nov;85(5):1218-1226. doi: 10.1016/j.jaad.2020.04.163. Epub 2020 May 5.

DOI:10.1016/j.jaad.2020.04.163

PMID:32387633

Abstract

BACKGROUND

Patch testing is the best diagnostic test for allergic contact dermatitis. However, there is presently a lack of data on the test's geographic availability and the characteristics of the providers offering this test across the United States.

OBJECTIVE

To evaluate the geographic variation in the availability of patch testing for the Medicare population and to characterize the temporal trends of patch testing cost, use, and provider specialty from 2012 to 2017.

METHODS

Retrospective cohort study of the Medicare Provider Utilization and Payment Data from 2012 to 2017.

RESULTS

As of 2017, patch testing was available in 20.3% of metropolitan counties and in 1.1% of nonmetropolitan counties. From 2012 to 2017 in metropolitan regions, the number of beneficiaries tested by dermatologists grew by an average annual growth rate of 1.84%, whereas those tested by allergists grew by an average annual growth rate of 20.31%. Most providers that averaged use of 80 or more patches per beneficiary were dermatologists (76.3%).

LIMITATIONS

Analysis was restricted to Medicare Part B claims; data were unavailable on individuals with commercial insurance.

CONCLUSIONS

Most of the increase in patch testing utilization from 2012 to 2017 has been in metropolitan regions. Although growth was especially prominent among allergists in metropolitan counties, the majority of providers performing comprehensive patch testing were dermatologists.

摘要

背景

斑贴试验是诊断变应性接触性皮炎的最佳检测方法。然而，目前美国缺乏关于该检测的地理可及性以及提供该检测的提供者特征的相关数据。

目的

评估美国医疗保险人群中斑贴试验的地理可及性差异，并描述 2012 年至 2017 年斑贴试验成本、使用和提供者专业的时间趋势。

方法

对 2012 年至 2017 年医疗保险提供者使用和支付数据进行回顾性队列研究。

结果

截至 2017 年，斑贴试验在 20.3%的都会县和 1.1%的非都会县提供。在都会地区，从 2012 年至 2017 年，皮肤科医生检测的受益人数平均每年增长 1.84%，而过敏科医生检测的受益人数平均每年增长 20.31%。平均每位受益患者使用 80 个或更多贴片的大多数提供者为皮肤科医生（76.3%）。